Possibilities of nimesulid administration in pediatric rheumatology
Objective. To analyze nimesulid efficacy and safety in children with reactive and juvenile chronic arthritis. Material and methods. 108 children aged 1,5 to 18 years receiving niomesulid (Doctor Reddi’s Laboratories Ltd, India) from 3,0 to 5,0 mg/kg/day as the main anti-inflammatory drug were includ...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2008-10-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/559 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|